https://www.selleckchem.com/products/th1760.html
To evaluate the utilisation of technologies and associated glycaemia among adults with type 1 diabetes. De-identified data from adults with type 1 diabetes (≥18years old) in the Australian National Diabetes Audit (ANDA)-2019 were analysed. Proportions using insulin pumps or injections with continuous glucose monitoring (CGM) or capillary-glucose testing were compared. Technology use among adults was compared to young people (21years old) with subsidised CGM. Glycaemia and complication-burden were assessed across management strategies
Like
Comment
Share
